Letrozole – Solution, 2.5mg/mL @ 30mL

Letrozole – Solution, 2.5mg/mL @ 30mL

$35.00 $8.00

Concentration: 2.5mg per mL, 75mg/30mL total; includes 1mL pipette.

In stock

Bulk Pricing
1 2-4 5-9 10-19 20-49 50+
$8.00 $7.20 $6.40 $5.60 $4.80 $4.00
000

Read the Specification Before Buying:

Application Aromatase Inhibitor
CAS 112809-51-5
Molar Mass 285.31 g/mol
Chemical Formula C17H11N5
Chemical Name 4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile
Synonyms Letrozole, 112809-51-5, Femara, 4,4′-((1h-1,2,4-triazol-1-yl)methylene)dibenzonitrile, Letrozol, CGS 20267, CGS-20267, Letoval, LETRAZOLE, Femera, Letrozole [USAN:INN], UNII-7LKK855W8I, 4,4′-(1H-1,2,4-triazol-1-ylmethanediyl)dibenzonitrile, Femara (TN), Benzonitrile, 4,4′-(1H-1,2,4-triazol-1-ylmethylene)bis-, LEROZOLE, HSDB 7461, 4-[(4-CYANOPHENYL)(1H-1,2,4-TRIAZOL-1-YL)METHYL]BENZONITRILE, 4,4′-(1h-1,2,4-triazol-1-ylmethylene)bisbenzonitrile, C17H11N5, 1-[bis(4-cyanophenyl)methyl]-1,2,4-triazole, CHEMBL1444, Letrozole (JAN/USP/INN), 4,4′-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile, 4,4′-(1h-1,2,4-triazol-1-ylmethylene)bis-benzonitrile, 7LKK855W8I, CHEBI:6413, 4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile, FEM-345, HPJKCIUCZWXJDR-UHFFFAOYSA-N, MFCD00866241, 4,4′-(1h-1,2,4-triazol-1-ylmethylene) bis-benzonitrile, NCGC00016973-01, CAS-112809-51-5, DSSTox_CID_3202, DSSTox_RID_76924, 1-[Bis-(4-cyanophenyl)methyl]-1,2,4-triazole, DSSTox_GSID_23202, Q-201291, 4,4′-(1H-1,2,4-triazol-1-ylmethylene)bis-Benzonitrile, Letrozole, 4-[1-(4-CYANOPHENYL)-1-(1,2,4-TRIAZOL-1-YL)METHYL]BENZONITRILE, SMR000466343, SR-01000759382, CCRIS 8822, Femara, Letrozole, Letrozole [USAN:USP:INN:BAN], LETROZ, LETROF L LIL, AC1L1GYT, Prestwick0_001025, Prestwick1_001025, Prestwick2_001025, Prestwick3_001025, Femara (TN) (Novartis), D0C1WH, Novartis Brand of Letrozole, SCHEMBL4331, BIDD:PXR0130, BSPBio_001209, MLS000759455, MLS001424038, MLS002584991, MLS006010040, BIDD:GT0015, Bio-0057, SPBio_003070, BPBio1_001331, GTPL5209, DTXSID4023202, Letrozole, >=98% (HPLC), BDBM13061, CTK8B5413, EX-A965, QCR-225, 4,4′-(1H-1,2,4-triazol-1-yl-methylene)-bis(benzonitrile), HMS1571M11, HMS2051E08, HMS2089L22, HMS2098M11, HMS2233C23, HMS3369E11, HMS3393E08, HMS3651K05, Pharmakon1600-01502354, CGS-20267 pound>>LETROZOLE, KS-00000XA8, ZINC3778874, Tox21_110719, Tox21_303572, ABP001083, ANW-48664, BG0620, NSC719345, NSC759652, s1235, STL451047, AKOS005145822, AB07525, AC-1193, AN-6525, API0024524, BCP9000848, CCG-100849, CS-1776, DB01006, KS-1269, NC00099, NSC-719345, NSC-759652, RP29922, RTC-070977, NCGC00016973-02, NCGC00016973-03, NCGC00016973-06, NCGC00257460-01, 4CA-0737, AJ-45577, AK-59607, BC205693, BR-59607, CPD000466343, HY-14248, LS-38788, SAM001246649, SC-00402, BCP0726000213, AB0012832, AB1009309, AX8041188, CGS 20267, Femara, Piroxicam, Letrozole, KB-187805, ST2405214, TL8000371, 1-Bis(4-cyanophenyl)methyl-1,2,4-triazole, 4,2,4-Triazol-1-ylmethylene)dibenzonitrile, AB00514009, FT-0627797, L0248, A25380, C08163, D00964, EN300-264820, J10423, S-4137, AB00514009-05, AB00514009-07, AB00514009-08, AB00514009-09, AB00514009_10, AB00514009_11, 809L515, W-60273, 4,4′-(1,2,4-Triazol-1-ylmethylene)dibenzonitrile, I06-0022, SR-01000759382-4, SR-01000759382-5, BRD-K88789588-001-03-2, 4,4 -(1H-1,2,4-triazol-1-ylmethanediyl)dibenzonitrile, 4,4′-(1,2,4-TRIAZOL-1-YLMETHYL)DIBENZONITRILE 4,4′-(1h-1,2,4-triazol-1-ylmethylene)-bisbenzonitrile, F2173-0288, Z1741968261, Letrozole, European Pharmacopoeia (EP) Reference Standard, Letrozole, United States Pharmacopeia (USP) Reference Standard, Letrozole, Pharmaceutical Secondary Standard; Certified Reference Material, 4,4 inverted exclamation marka-(1H-1,2,4-Triazol-1-ylmethylene)bisbenzonitrile
Storage Store at room temperature, tightly sealed, away from heat, light and moisture.
Solubility PEG-400, Ethanol
Organoleptic Profile Clear liquid
Physical Form Solution with PEG-400, Ethanol
Reports HPLC
Terms The products we offer are intended for laboratory research use only.
Please familiarize yourself with our Terms & Conditions prior to ordering.